| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0003 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.19 | 0.0007 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0008 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.21 | 0.0009 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.093 | 0.002 |